StemCell Institute: Notice regarding the year-end dividend forecast for the 2nd quarter (dividend commemorating the 25th anniversary of establishment (first dividend)) for the fiscal year ending March 31, 2025
StemCell Institute: Financial results presentation materials for the fiscal year ending March 2024
StemCell Institute: Summary of financial results for the fiscal year ending March 31, 2024 [Japanese GAAP] (unconsolidated)
StemCell Institute: Extraordinary Report
StemCell Institute: Notice Concerning the Recording of Gains (Extraordinary Profit) from the Sale of Investment Securities
Stemcell Research Institute: Quarterly Report - 25th Quarter 3rd Quarter (2023/10/01 - 2023/12/31)
Stem Cell Laboratory: Confirmation
StemCell Institute: Supplementary explanation of financial results for the 3rd quarter of the fiscal year ending March 31, 2024
StemCell Institute: Summary of financial results for the 3rd quarter of the fiscal year ending March 31, 2024 [Japanese GAAP] (unconsolidated)
StemCell Institute: Notice regarding executive officers, general personnel affairs, and organizational restructuring
StemCell Institute: Notice regarding the selection of loan stocks for our shares
StemCell Institute: Confirmation letter
StemCell Institute: Quarterly Report - 25th Second Quarter (2023/07/01 - 2023/09/30)
StemCell Institute: Summary of financial results for the 2nd quarter of the fiscal year ending March 31, 2024 [Japanese GAAP] (unconsolidated)
StemCell Institute: Supplementary explanation of financial results for the 2nd quarter of the fiscal year ending March 31, 2024
StemCell Institute: Notice regarding the capital and business alliance between Stemcell Research Institute Co., Ltd. and Japan Medical Company Co., Ltd.
StemCell Institute: Confirmation letter
StemCell Institute: Quarterly Report - Q25, 1st Quarter (2023/04/01 - 2023/06/30)
StemCell Institute: Supplementary briefing materials on financial results for the first quarter of the fiscal year ending March 31, 2024
StemCell Institute: Summary of Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Unconsolidated)
No Data